Skip to main content

Pharvaris N.V 6-K, filed Nov 12, 2026

Pharvaris N.V. (PHVS)

6-K 2026-11-12 For: 2026-11-12
View Original
Added on November 12, 2026

About this 6-K

Pharvaris N.V filed this 6-K on November 12, 2026.

Pharvaris reported the FDA PDUFA target action date for deucrictibant IR is April 23, 2027; CREAATE part 1 topline data are expected in 1Q2027. Cash and cash equivalents were €283 million, and quarterly loss was €47.4 million. AI summary